10/29/2019 2:57:32 AM
Akastor ASA Q3 Revenues Of NOK 1.4 Bln, Increase Of 50% Y-o-Y
2/15/2019 6:13:19 AM
Achaogen Announces Pricing Of $15 Mln Underwritten Public Offering
12/10/2018 8:05:34 AM
Achaogen Announces FDA Clearance And Launch Of Thermo Scientific QMS Plazomicin Immunoassay
11/12/2018 6:28:29 AM
Wedbush Is Cutting Achaogen Inc. (AKAO) FY18 Rev. Estimate To 8.9 M From 12.4 M
11/12/2018 6:28:15 AM
Wedbush Is Lowering Achaogen Inc. (AKAO) Q4 18 Rev. Estimate To 2.2 M From 4.5 M
11/12/2018 6:27:46 AM
Wedbush Is Increasing Achaogen Inc. (AKAO) FY18 Estimate To -3.82 From -4.12
11/12/2018 6:27:28 AM
Wedbush Is Raising Achaogen Inc. (AKAO) Q4 18 Estimate To -0.71 From -0.74
11/12/2018 6:27:04 AM
Wedbush Cuts Achaogen Inc. (AKAO) To Neutral From Outperform With $3 Down From $17 Price Target
11/8/2018 8:14:44 AM
Achaogen Q3 Loss Per Share $1.02 Vs Loss $0.85 Last Year
10/17/2018 8:03:55 AM
Achaogen Submits Marketing Authorization Application To EMA For Plazomicin
8/9/2018 9:14:18 AM
Wedbush Is Lowering Achaogen Inc. (AKAO) FY18 Estimate To -4.12 From -3.65
8/9/2018 9:14:02 AM
Wedbush Is Increasing Achaogen Inc. (AKAO) Q4 18 Estimate To -0.74 From -0.82
8/9/2018 9:13:50 AM
Wedbush Is Cutting Achaogen Inc. (AKAO) Q3 18 Estimate To -1.20 From -0.82